Related Experiment Video
Updated: Jul 17, 2026
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Suspected paclitaxel-induced pneumonitis
Kohei Shitara1, Eiji Ishii, Makoto Kondo
1Department of Medical Oncology, Misawa City Hospital, 4-1-10 Chyuo-cho, Misawa, Aomori, 033-0001, Japan.
Summary
Paclitaxel, a chemotherapy drug, can cause rare but fatal interstitial pneumonitis in advanced gastric cancer patients. Early recognition of symptoms like cough and dyspnea is crucial for diagnosis.
Area of Science:
- Oncology
- Pulmonology
- Pharmacology
Background:
- Gastric cancer is a significant global health concern.
- Paclitaxel is a widely used chemotherapeutic agent for various cancers, including gastric cancer.
- Interstitial pneumonitis is a known, albeit rare, adverse effect of some chemotherapeutic agents.
Observation:
- Two male patients with advanced gastric cancer developed interstitial pneumonitis during paclitaxel treatment.
- Symptoms included nonproductive cough and dyspnea, with CT scans revealing bilateral ground-glass attenuation.
- Neither patient responded to corticosteroid treatment, and both deceased shortly after paclitaxel cessation.
Findings:
- Paclitaxel administration was temporally associated with the onset of interstitial pneumonitis in both cases.
- The observed pneumonitis was severe and refractory to standard corticosteroid therapy.
- Autopsy findings were not detailed, but the clinical course suggests drug-induced lung injury.
Implications:
- Paclitaxel-induced interstitial pneumonitis should be considered in the differential diagnosis of respiratory symptoms in gastric cancer patients receiving paclitaxel.
- Prompt recognition and potential discontinuation of paclitaxel may be warranted.
- Further research into the mechanisms and management of paclitaxel-induced lung injury is needed.
Related Concept Videos
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: